Although several therapeutic agents have been evaluated for the treatment of COVID-19, none have yet shown to be effective.
In an interview with Drug Topics®, Richard Scholz, chief strategy officer of ERxDirect, explained the prominence of telemedicine during the COVID-19 pandemic and the lasting implications of new technologies during unprecedented times.
New data showed that treatment with hydroxychloroquine was associated with increased mortality in hospitalized patients with COVID-19.
Officials with the FDA have approved Octapharma’s investigational new drug (IND) application for intravenous immune globulin (IVIG) (Human, Octagam 10%) therapy.
A close look at their potential to interact with other medications is required to limit the risk of adverse outcomes for patients.
Coronavirus News Roundup: Progress in Vaccine Development, Clarification on Pharmacist-Provided Testing
Here's a roundup of the latest coronavirus-related news.
In part 2 of our interview, Mike Johnston, founder and chief executive officer of the National Pharmacy Technician Association (NPTA), discussed the results of their recent survey, which found that many pharmacists and pharmacy technicians feel unsafe from COVID-19 at their workplaces.
AstraZeneca has received funds exceeding $1 billion from the US Biomedical Advanced Research and Development Authority (BARDA) for the development, production, and delivery of the University of Oxford’s coronavirus disease 2019 (COVID-19) vaccine candidate.
The US Department of Health & Human Services partners with Phlow Corporation team to prevent drug shortages during the current pandemic and in future public health emergencies.
A new guidance from the US Department of Health & Human Services (HHS) paves the way for pharmacists nationwide to administer coronavirus disease 2019 (COVID-19) tests.